NASDAQ$AONC
American Oncology Network In · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Reports awaiting report
American Oncology Network hasn't published Q1 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q3 2024
- Revenue
- $434M
- EPS
- -$740.00
Year-ago · Q1 2024 Q1 2024
- Revenue
- $364M
- EPS
- -$1.22
Revenue & EPS history
American Oncology Network · Revenue · Quarterly
$434M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 1 quarterly earnings reports · overlaid with Q1 2025
-1.0%
Avg return
Earnings day
-7.8%
Avg return
5 days after
-4.0%
Avg return
30 days after
40%
2 / 5 earnings
Positive
+3.3%
Q1 2025
Best reaction
-4.4%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2025 | +3.3% | -0.8% | -11.7% | |
| Q3 2024 | +1.1% | -14.8% | +3.7% | |
| Q2 2024 | -0.9% | — | — | |
| Q1 2024 | — | — | — | |
| Q4 2023 | -4.4% | — | — | |
| Q3 2023 | -4.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro